ICU Medical, Inc. (ICUI)

NASDAQ: ICUI · IEX Real-Time Price · USD
165.00
+0.19 (0.12%)
Jul 7, 2022 12:25 PM EDT - Market open
0.12%
Market Cap 3.94B
Revenue (ttm) 1.54B
Net Income (ttm) 41.34M
Shares Out 23.90M
EPS (ttm) 2.09
PE Ratio 78.95
Forward PE 18.38
Dividend n/a
Ex-Dividend Date n/a
Volume 20,759
Open 164.92
Previous Close 164.81
Day's Range 164.74 - 166.80
52-Week Range 158.60 - 282.00
Beta 0.49
Analysts Buy
Price Target 273.70 (+65.9%)
Earnings Date Aug 3, 2022

About ICUI

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana... [Read more...]

Industry Health Care Equipment & Supplies
IPO Date Mar 31, 1992
CEO Vivek Jain
Employees 15,300
Stock Exchange NASDAQ
Ticker Symbol ICUI
Full Company Profile

Financial Performance

In 2021, ICU Medical's revenue was $1.32 billion, an increase of 3.56% compared to the previous year's $1.27 billion. Earnings were $103.14 million, an increase of 18.72%.

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for ICUI stock is "Buy." The 12-month stock price forecast is 273.7, which is an increase of 65.88% from the latest price.

Price Target
$273.7
(65.88% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Raymond James Says 'Supply Chain Challenges Made Q1 Messy' For This Medtech Stock

ICU Medical Inc (NASDAQ: ICUI) reported Q1 sales of $543.1 million vs. Raymond James' estimate of $530 million.

ICU Medical (ICUI) Surpasses Q1 Earnings Estimates

ICU Medical (ICUI) delivered earnings and revenue surprises of 1.68% and 0.67%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

ICU Medical, Inc. Announces Time of First Quarter 2022 Earnings Conference Call

SAN CLEMENTE, Calif., April 20, 2022 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of it...

ICU Medical (ICUI) is a Great Momentum Stock: Should You Buy?

Does ICU Medical (ICUI) have what it takes to be a top stock pick for momentum investors? Let's find out.

Buy These 4 Low-Beta Stocks to Combat the Choppy Market

It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Meridian (VIVO), OP Bancorp (OPBK), ICU Medical (ICUI) and Pangaea Logistics (PANL) are well poised to gain.

Other symbols: OPBKPANLVIVO

Is ICU Medical (ICUI) a Solid Growth Stock? 3 Reasons to Think " Yes "

ICU Medical (ICUI) possesses solid growth attributes, which could help it handily outperform the market.

ICU Medical, Inc. to Participate at the KeyBanc Life Sciences & MedTech Investor Forum

SAN CLEMENTE, Calif., March 14, 2022 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that company m...

Looking for a Growth Stock? 3 Reasons Why ICU Medical (ICUI) is a Solid Choice

ICU Medical (ICUI) is well positioned to outperform the market, as it exhibits above-average growth in financials.

ICU Medical, Inc. to Participate at the Raymond James 43rd Annual Institutional Investors Conference

SAN CLEMENTE, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company m...

ICU Medical (ICUI) Surpasses Q4 Earnings and Revenue Estimates

ICU Medical (ICUI) delivered earnings and revenue surprises of 11.66% and 6.30%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate ICU Medical (ICUI) to Report a Decline in Earnings: What to Look Out for

ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ICU Medical Announces Time of Fourth Quarter 2021 Earnings Conference Call

SAN CLEMENTE, Calif., Feb. 04, 2022 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its...

3 Reasons Why ICU Medical (ICUI) Is a Great Growth Stock

ICU Medical (ICUI) possesses solid growth attributes, which could help it handily outperform the market.

ICU Medical Completes the Acquisition of Smiths Medical from Smiths Group plc

SAN CLEMENTE, Calif. , Jan. 6, 2022 /PRNewswire/ -- ICU Medical Inc. (NASDAQ: ICUI) announced that it has completed its acquisition of Smiths Medical from Smiths Group plc (LSE: SMIN.L).

ICU Medical, Inc. to Present at the J.P. Morgan 40th Annual Healthcare Conference

SAN CLEMENTE, Calif., Dec. 29, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and cri...

ICU Medical (ICUI) Q3 Earnings and Revenues Surpass Estimates

ICU Medical (ICUI) delivered earnings and revenue surprises of 15.64% and 6.96%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

ICU Medical, Inc. Announces Third Quarter 2021 Results

SAN CLEMENTE, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and cri...

ICU Medical, Inc. Announces Time of Third Quarter 2021 Earnings Conference Call

SAN CLEMENTE, Calif., Oct. 13, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and cri...

10 Expensive Stocks to Steer Clear Of

Expensive stocks with mediocre growth prospects can drop the most when the whole market starts to slide. These 10 stocks could be at high risk.

ICU Medical Pulls Amino Acid IV Products After Foreign Substances Found In Batch

ICU Medical Inc (NASDAQ: ICUI), a California-based infusion therapy company, is voluntarily recalling one lot of an amino acid injection after reports of fibers, hair, and other particles of foreign mat...

Why ICU Medical Stock Is Jumping Today

A leading manufacturer of intravenous therapy solutions is about to get a lot bigger.

Why ICU Medical Shares Surged Today

ICU Medical (NASDAQ: ICUI) shares are trading higher after the company announced it will acquire Smiths Medical division from Smiths Group PLC for $2.35 billion in cash and stock. The Smiths Medical bus...

ICUI Stock: What Is the Huge News Sending ICU Medical Soaring 35% Today

Today, a big acquisition deal has sent shares of ICU Medical more than 30% higher as investors and speculators buy into ICUI stock. The post ICUI Stock: What Is the Huge News Sending ICU Medical Soaring...

Smiths Group Divests Its Medical Division To ICU Medical In $2.4B Deal

ICU Medical Inc (NASDAQ: ICUI) has agreed to acquire Smiths Group plc's Medical division in a transaction that will create an IV therapy company and simplify customer workflow.  The Smiths Medical busin...

ICU Medical, Inc. to acquire Smiths Medical division from Smiths Group plc for $2.35 billion in cash and stock plus t...

The addition of Smiths Medical syringe and ambulatory infusion devices, vascular access, and vital care products into ICU Medical creates a leading infusion therapy company with a stronger global reach